18 Apr 2019

MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

This alert highlights two reports of fatal adverse reactions to yellow fever vaccine and the importance of a detailed risk assessment before vaccination MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has published an alert following two fatal adverse reactions to yellow fever vaccine. This publication reinforces the importance of a detailed individual risk assessment before administering yellow fever vaccine especially for those who may be immunocompromised or aged 60 years and older. 

NaTHNaC have been working closely with the MHRA following these two reports of fatal adverse reactions. Measures to minimise risks are being reviewed by an Expert Working Group convened by the Commission on Human Medicines and any updates will be highlighted in due course.

Resources

Public Health England becomes UK Health Security Agency

On 1 October 2021 PHE officially becomes the UK Health Security Agency (UKHSA) Read more

Updated rabies post-exposure guidelines

Public Health England have published updated rabies post-exposure treatment guidelines Read more

Volcanic eruption in La Palma, Canary Islands, Spain

Volcanic eruptions can cause widespread damage, disruption and pose multiple health threats Read more

Update: No evidence of Ebola virus disease in Côte d’Ivoire

Further laboratory tests from a patient suspected of having Ebola virus disease have found no evidence of the virus Read more

Polio: Public Health Emergency of International Concern

An update on the polio Public Health Emergency of International Concern (PHEIC) Read more
Back to Top

VIEW FULL INDEX